CL vs IPCXR · P/E 34, rev $10.69B vs rev $100.0M
Colgate-Palmolive Company (CL) versus Inflection Point Acquisition Corp. III Rights (IPCXR) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Inflection Point Acquisition Corp. III Rights (IPCXR) common stock listed on US.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported IPCXR revenue for 2025-09-30 was $100.0M. Net income was -$90.8K. IPCXR currently screens at market cap $0.
CL currently screens at market cap $70.88B and trailing P/E 34.3. IPCXR currently screens at market cap $0.
Not investment advice. Open the CL and IPCXR stock pages for the full models.
Not investment advice.